Primary bioavailability parameters of loratadine in CYP2D6 extensive metabolizers

被引：0
|
作者：
Kunicki, PK
Gutkowski, P
机构：
[1] Natl Inst Cardiol, Dept Clin Biochem, Clin Pharmacol Unit, Warsaw, Poland
[2] TRIAL Clin Res Ctr, Warsaw, Poland
来源：
THERAPEUTIC DRUG MONITORING | 2003年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
156
引用
收藏
页码：525 / 525
页数：1
相关论文
共 50 条
  • [31] Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype
    Wollmann, Birgit M.
    Storset, Elisabet
    Kringen, Marianne Kristiansen
    Molden, Espen
    Smith, Robert L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (04) : 523 - 531
  • [32] The effect of dacomitinib (PF-00299804) on CYP2D6 activity in healthy volunteers who are extensive or intermediate metabolizers
    Bello, Carlo L.
    LaBadie, Robert R.
    Ni, Grace
    Boutros, Tanya
    McCormick, Carol
    Ndongo, M. Noella
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 991 - 997
  • [33] The effect of dacomitinib (PF-00299804) on CYP2D6 activity in healthy volunteers who are extensive or intermediate metabolizers
    Carlo L. Bello
    Robert R. LaBadie
    Grace Ni
    Tanya Boutros
    Carol McCormick
    M. Noella Ndongo
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 991 - 997
  • [34] ASSESSING THE PHARMACOKINETICS OF VENLAFAXINE ER 75 MG AND DESVENLAFAXINE 50 MG IN CYP2D6 EXTENSIVE AND POOR METABOLIZERS
    Kane, Cecelia
    Nichols, Alice
    Focht, Kristen
    Jiang, Qin
    Preskorn, Sheldon
    Burczynski, Ted
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 : A57 - A57
  • [35] Infant Dextromethorphan and Dextrorphan Exposure via Breast Milk From Mothers Who Are CYP2D6 Extensive Metabolizers
    Shum, Sara
    Yadav, Aprajita
    Fay, Emily
    Moreni, Sue
    Mao, Jennie
    Czuba, Lindsay
    Wang, Celine
    Isoherranen, Nina
    Hebert, Mary F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (06): : 747 - 755
  • [36] The effects of concomitant administration of theophylline and toborinone on the pharmacokinetics of both compounds in poor and extensive metabolizers via CYP2D6
    Tammara, B
    Trang, JM
    Miyamoto, G
    Kitani, M
    Brisson, J
    Bramer, SL
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (05): : 492 - 500
  • [37] Low frequency of CYP2D6 poor metabolizers among schizophrenia patients
    A LLerena
    P Dorado
    E M Peñas-LLedó
    M C Cáceres
    A De la Rubia
    The Pharmacogenomics Journal, 2007, 7 : 408 - 410
  • [38] Low frequency of CYP2D6 poor metabolizers among schizophrenia patients
    LLerena, A.
    Dorado, P.
    Penas-LLedo, E. M.
    Caceres, M. C.
    De la Rubia, A.
    PHARMACOGENOMICS JOURNAL, 2007, 7 (06): : 408 - 410
  • [39] Increased heart rate response to metoprolol in CYP2D6 poor metabolizers
    Wuttke, H
    Rau, T
    Michels, L
    Bergmann, K
    Kreft, M
    Eschenhagen, T
    CIRCULATION, 2005, 112 (17) : U412 - U412
  • [40] CYP2D6 poor metabolizers in depressed women of Mexican origin.
    Flores, DL
    Flockhart, D
    Licinio, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P41 - P41
12345